Phototherapy and photochemotherapy for psoriasis.

[1]  Mali Jw,et al.  [The treatment of psoriasis]. , 1975, Nederlands tijdschrift voor geneeskunde.

[2]  H. Hönigsmann,et al.  Phototesting and dosimetry for photochemotherapy , 1977, The British journal of dermatology.

[3]  J. Parrish,et al.  Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. , 1977, The Journal of investigative dermatology.

[4]  J. Parrish,et al.  Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis , 1978, The British journal of dermatology.

[5]  R. Naik,et al.  Nail pigmentation due to oral 8‐methoxypsoralen , 1979, The British journal of dermatology.

[6]  S. M. Berger,et al.  Tar gel-phototherapy for psoriasis. Combined therapy with suberythemogenic doses of fluorescent sunlamp ultraviolet radiation. , 1979, Archives of dermatology.

[7]  J. Parrish,et al.  SKIN CARCINOMA IN PATIENTS WITH PSORIASIS TREATED WITH TOPICAL TAR AND ARTIFICIAL ULTRAVIOLET RADIATION , 1980, The Lancet.

[8]  D. Pariser,et al.  Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA). , 1980, Journal of the American Academy of Dermatology.

[9]  H. Hönigsmann,et al.  ORAL 8-METHOXYPSORALEN PHOTOCHEMOTHERAPY OF PSORIASIS The European PUVA Study: a Cooperative Study among 18 European Centres , 1981, The Lancet.

[10]  L. Harber.  [Photochemotherapy for psoriasis]. , 1974, Krankenpflege.

[11]  O. Larkö,et al.  Is UVB treatment of psoriasis safe? A study of extensively UVB-treated psoriasis patients compared with a matched control group. , 1982, Acta dermato-venereologica.

[12]  H. Hönigsmann,et al.  Phototherapy for psoriasis , 2001, Clinical and experimental dermatology.

[13]  F. Noonan,et al.  Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology , 1983, The Journal of experimental medicine.

[14]  L. Taylor,et al.  Coal tar phototherapy for psoriasis reevaluated: erythemogenic versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar. , 1983, Journal of the American Academy of Dermatology.

[15]  J. Petrozzi.  Topical steroids and UV radiation in psoriasis. , 1983, Archives of dermatology.

[16]  R. Stern,et al.  Ocular findings in patients treated with PUVA. , 1985, The Journal of investigative dermatology.

[17]  R. Stern,et al.  Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. , 1986, Journal of the American Academy of Dermatology.

[18]  F. Wolff,et al.  Clinical Pharmacokinetics of Methoxsalen and Other Psoralens , 1986, Clinical pharmacokinetics.

[19]  R. MacKie,et al.  Cutaneous and ocular side‐effects of oral photochemotherapy: results of an 8‐year follow‐up study , 1987, The British journal of dermatology.

[20]  H. Hönigsmann,et al.  5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation. , 1988, Journal of the American Academy of Dermatology.

[21]  J. Ferguson,et al.  Ultraviolet Radiation Phototherapy for Psoriasis The Use of a New Narrow Band Uvb Fluorescent Lamp , 1988 .

[22]  J. Ferguson,et al.  311 nm UVB phototherapy—an effective treatment for psoriasis , 1988, The British journal of dermatology.

[23]  J. C. Leun,et al.  A new development in UVB phototherapy of psoriasis , 1988, The British journal of dermatology.

[24]  R. Stern,et al.  Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. , 1988, The Journal of investigative dermatology.

[25]  D. Averbeck.  RECENT ADVANCES IN PSORALEN PHOTOTOXICITY MECHANISM , 1989, Photochemistry and photobiology.

[26]  R. Stern,et al.  Are topical corticosteroids useful in phototherapy for psoriasis? , 1989, Journal of the American Academy of Dermatology.

[27]  E. Ruotsalainen,et al.  311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen. , 1989, Acta dermato-venereologica.

[28]  O. Larkö.  Treatment of psoriasis with a new UVB-lamp. , 1989, Acta dermato-venereologica.

[29]  L. Chylack,et al.  Recent studies on photodamage to the eye with special reference to clinical phototherapeutic procedures. , 1990, Photodermatology, photoimmunology & photomedicine.

[30]  R. MacKie,et al.  Cutaneous malignancy in males treated with photochemotherapy , 1990, The Lancet.

[31]  J. Guilhou,et al.  Vitamin D metabolism in psoriasis before and after phototherapy. , 1990, Acta dermato-venereologica.

[32]  R. Stern.  Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. , 1990, The New England journal of medicine.

[33]  O. Braun-falco,et al.  Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis. , 1990, Archives of dermatology.

[34]  N. Soter,et al.  Acute effects of ultraviolet radiation on the skin. , 1990, Seminars in dermatology.

[35]  H. Hönigsmann,et al.  Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. , 1991, Journal of the American Academy of Dermatology.

[36]  A. Schothorst,et al.  “High single‐dose’ European PUVA regimen also causes an excess of non‐melanoma skin cancer , 1991, The British journal of dermatology.

[37]  R. Armstrong,et al.  Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. , 1991, Journal of the American Academy of Dermatology.

[38]  L. Meunier,et al.  Treatment of psoriasis with a 311‐nm UVB lamp , 1992, The British journal of dermatology.

[39]  P. C. Llins,et al.  Bath‐water compared with oral delivery of 8‐methoxypsoralen PUVA therapy for chronic plaque psoriasis , 1992 .

[40]  E. Snellman,et al.  Effect of psoriasis heliotherapy on epidermal urocanic acid isomer concentrations. , 1992, Acta dermato-venereologica.

[41]  B. Sredni,et al.  Effect of UVB and AS101 on interleukin-2 production and helper activity in psoriatic patients. , 1993, Natural immunity.

[42]  J. Thivolet,et al.  Calcipotriol in combination with PUVA: a randomized double blind placebo study in severe psoriasis , 1993 .

[43]  G. Plewig,et al.  Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. , 1993, Journal of the American Academy of Dermatology.

[44]  M. Norval,et al.  Effect of phototherapy and urocanic acid isomers on natural killer cell function. , 1993, The Journal of investigative dermatology.

[45]  H. Hönigsmann,et al.  Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis. , 1993, Journal of the American Academy of Dermatology.

[46]  B. Diffey,et al.  The practice of ultraviolet phototherapy in the United Kingdom , 1994, The British journal of dermatology.

[47]  R. Stern,et al.  The carcinogenic risk of treatments for severe psoriasis , 1994, Cancer.

[48]  P. Farr,et al.  Skin cancers or premalignant lesions occur in half of high‐dose PUVA patients , 1994, The British journal of dermatology.

[49]  P. Farr,et al.  Calcipotriol improves the response of psoriasis to PUVA , 1994, The British journal of dermatology.

[50]  E. Abel.  British Photodermatology Group guidelines for PUVA. , 1994, The British journal of dermatology.

[51]  N. Traynor,et al.  The phototumorigenic potential of broad-band (270-350 nm) and narrow-band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. , 1995, The Journal of investigative dermatology.

[52]  M. Kulesz-Martin,et al.  DNA damage in UVB-irradiated keratinocytes. , 1995, Carcinogenesis.

[53]  A. Gottlieb,et al.  Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells , 1995, The Journal of experimental medicine.

[54]  Michael Karin,et al.  Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine Receptors , 1996, Science.

[55]  J. Krueger,et al.  Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. , 1997, Archives of dermatology.

[56]  M. Norval,et al.  Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review. , 1997, Journal of photochemistry and photobiology. B, Biology.

[57]  P. Kerkhof,et al.  Multiple squamous cell carcinomas in a psoriatic patient following high–dose photochemotherapy and cyclosporin treatment: response to long–term acitretin maintenance , 1997 .

[58]  J. Bos,et al.  Prolonged Increase of cis‐Urocanic Acid Levels in Human Skin and Urine after Single Total‐body Ultraviolet Exposures , 1997, Photochemistry and photobiology.

[59]  R. Stern,et al.  Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. , 1997, The New England journal of medicine.

[60]  J. Koo,et al.  Calcipotriol/calcipotriene (Dovonex/Daivonex) in combination with phototherapy: a review. , 1997, Journal of the American Academy of Dermatology.

[61]  B. Nickoloff,et al.  Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). , 1998, The Journal of clinical investigation.

[62]  J. Koo.  Tazarotene in combination with phototherapy. , 1998, Journal of the American Academy of Dermatology.

[63]  R. Stern,et al.  Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. , 1998, Journal of the National Cancer Institute.

[64]  Cameron,et al.  Narrow‐band (TL‐01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? , 1998, The British journal of dermatology.

[65]  Thomas A. Luger,et al.  Ultraviolet Light Induces Apoptosis via Direct Activation of CD95 (Fas/APO-1) Independently of Its Ligand CD95L , 1998, The Journal of cell biology.

[66]  R. Panizzon,et al.  Carcinogenic Risk of Bath PUVA in Comparison to Oral PUVA Therapy , 1999, Dermatology.

[67]  Behrens,et al.  Combination treatment of psoriasis with photochemotherapy and tazarotene gel, a receptor‐selective topical retinoid , 1999, The British journal of dermatology.

[68]  L. Austin,et al.  312-nanometer Ultraviolet B Light (Narrow-Band UVB) Induces Apoptosis of  T Cells within Psoriatic Lesions , 1999, The Journal of experimental medicine.

[69]  M. Lebwohl.  Acitretin in combination with UVB or PUVA. , 1999, Journal of the American Academy of Dermatology.

[70]  A. Hannuksela-Svahn,et al.  Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA. , 1999, Journal of the American Academy of Dermatology.

[71]  Karvonen,et al.  Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis , 1999, The British journal of dermatology.

[72]  L. Molin.  Topical Calcipotriol Combined with Phototherapy for Psoriasis , 1999, Dermatology.

[73]  J. Krueger,et al.  Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. , 1999, Journal of the American Academy of Dermatology.

[74]  Priestley,et al.  A comparison of bathwater and oral delivery of 8‐methoxypsoralen in PUVA therapy for plaque psoriasis , 2000, Clinical and experimental dermatology.

[75]  K. Papp,et al.  Calcipotriol Cream Combined with Twice Weekly Broad-Band UVB Phototherapy: A Safe, Effective and UVB-Sparing Antipsoriatric Combination Treatment , 2000, Dermatology.

[76]  J. Cuzick,et al.  Photoadaptation to ultraviolet (UV) radiation in vivo: photoproducts in epidermal cells following UVB therapy for psoriasis. , 2000, The British journal of dermatology.

[77]  J. Cuzick,et al.  Photoadaptation to ultraviolet (UV) radiation in vivo: photoproducts in epidermal cells following UVB therapy for psoriasis , 2000 .

[78]  O. Braun-falco,et al.  Physical Methods of Therapy , 2000 .

[79]  F. Nestle,et al.  Clinical Efficacy of Narrow-Band UVB (311 nm) Combined with Dithranol in Psoriasis , 2000, Dermatology.

[80]  M. Kerscher,et al.  Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis , 2000, The British journal of dermatology.

[81]  M. Lebwohl,et al.  Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. , 2001, Journal of the American Academy of Dermatology.

[82]  R. Stern.  The risk of melanoma in association with long-term exposure to PUVA. , 2001, Journal of the American Academy of Dermatology.

[83]  Serish,et al.  Minimal erythema dose (Med) to narrow band ultraviolet-B (NB-UVB) broad band ultraviolet-B (BB-UVB)--a pilot study. , 2002 .

[84]  H. Hönigsmann,et al.  Objective assessment of photoageing effects using high‐frequency ultrasound in PUVA‐treated psoriasis patients , 2002, The British journal of dermatology.

[85]  H. Ockenfels,et al.  Ultraviolet B 308‐nm excimer laser treatment of psoriasis: a new phototherapeutic approach , 2003, The British journal of dermatology.

[86]  J. Bos,et al.  Ultraviolet‐B irradiation decreases IFN‐γ and increases IL‐4 expression in psoriatic lesional skin in situ and in cultured dermal T cells derived from these lesions , 2003, Experimental dermatology.

[87]  J. Krueger,et al.  Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. , 2003, Archives of dermatology.

[88]  S. Rogers,et al.  Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. , 2003, Archives of dermatology.

[89]  K. Hemminki,et al.  Effect of the spectral range of a UV lamp on the production of cyclobutane pyrimidine dimers in human skin in situ , 2003, Photodermatology, photoimmunology & photomedicine.

[90]  J. Bos,et al.  IL-4 Expression by Neutrophils in Psoriasis Lesional Skin upon High-Dose UVB Exposure , 2003, Dermatology.

[91]  Assessment of the usefulness of skin phototype and skin color as the parameter of cutaneous narrow band UVB sensitivity in psoriasis patients , 2003, Photodermatology, photoimmunology & photomedicine.

[92]  J. Bos,et al.  T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-γ expression , 2004, Archives of Dermatological Research.

[93]  A. Schothorst,et al.  Influence of water and salt solutions on UVB irradiation of normal skin and psoriasis , 2004, Archives of Dermatological Research.

[94]  A. Blum,et al.  No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. , 2004, Acta dermato-venereologica.

[95]  C. Esser,et al.  Ultraviolet B radiation-induced immunosuppression: molecular mechanisms and cellular alterations , 2005, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[96]  J. Gudjonsson,et al.  Narrowband–UVB irradiation decreases the production of pro-inflammatory cytokines by stimulated T cells , 2005, Archives of Dermatological Research.

[97]  M. Smid,et al.  Differential Role of Basal Keratinocytes in UV-Induced Immunosuppression and Skin Cancer , 2006, Molecular and Cellular Biology.

[98]  P. Asawanonda,et al.  Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study. , 2006, Journal of the American Academy of Dermatology.

[99]  R. Stern.  Psoralen and ultraviolet a light therapy for psoriasis. , 2007, The New England journal of medicine.

[100]  F. Wolfe,et al.  Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. , 2007, Arthritis and rheumatism.

[101]  H. Hönigsmann,et al.  The acute effects of ultraviolet radiation on the skin. , 2007 .

[102]  H. Kerl,et al.  Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis. , 2007, Archives of dermatology.

[103]  Vinod K. Sharma,et al.  Determination of minimal erythemal dose for narrow band-ultraviolet B radiation in north Indian patients: comparison of visual and Dermaspectrometer readings. , 2007, Indian journal of dermatology, venereology and leprology.

[104]  J. Matthews,et al.  A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis. , 2007, The Journal of investigative dermatology.

[105]  S Grover,et al.  Fitzpatrick's Dermatology in General Medicine , 2008 .

[106]  C. Elmets,et al.  Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. , 2008, Journal of drugs in dermatology : JDD.

[107]  R. Dawe,et al.  Incidence of skin cancers in 3867 patients treated with narrow‐band ultraviolet B phototherapy , 2008, The British journal of dermatology.

[108]  K. Scharffetter-Kochanek,et al.  Phototherapy and photochemotherapy. , 2008, Clinics in dermatology.

[109]  M. Lebwohl,et al.  Nonstandard and off-label therapies for psoriasis. , 2008, Clinics in dermatology.

[110]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. , 2008, Journal of the American Academy of Dermatology.

[111]  L. Naldi,et al.  European S3‐Guidelines on the systemic treatment of psoriasis vulgaris , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[112]  H. Kerl,et al.  Treatment with 311‐nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept , 2009, The British journal of dermatology.

[113]  A. Finlay,et al.  British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009 , 2009, The British journal of dermatology.

[114]  Feasibility and accuracy of a newly developed hand‐held device with a flat‐type fluorescent lamp for measuring the minimal erythema dose for narrow‐band UVB therapy , 2009, Photodermatology, photoimmunology & photomedicine.

[115]  E. Buskens,et al.  Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study) , 2009, BMJ : British Medical Journal.

[116]  A. Wennberg,et al.  Vitamin D production in psoriasis patients increases less with narrowband than with broadband ultraviolet B phototherapy , 2009, Photodermatology, photoimmunology & photomedicine.

[117]  M. Davis,et al.  Goeckerman treatment for remission of psoriasis refractory to biologic therapy. , 2009, Journal of the American Academy of Dermatology.

[118]  B. Kirby,et al.  The effects of phototherapy on the numbers of circulating natural killer cells and T lymphocytes in psoriasis , 2009, Photodermatology, photoimmunology & photomedicine.

[119]  C. Ryan,et al.  Clinical and genetic predictors of response to narrowband ultraviolet B for the treatment of chronic plaque psoriasis , 2010, The British journal of dermatology.

[120]  D. Bandyopadhyay,et al.  Indian J Dermatol Venereol Leprol , 2010 .

[121]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. , 2010, Journal of the American Academy of Dermatology.

[122]  E. Buskens,et al.  Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study) , 2010, BMJ : British Medical Journal.

[123]  S. Feldman,et al.  A review of phototherapy protocols for psoriasis treatment. , 2011, Journal of the American Academy of Dermatology.

[124]  W. V. van IJcken,et al.  Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways. , 2011, The Journal of investigative dermatology.

[125]  W. Weger,et al.  311 nm ultraviolet B‐accelerated response of psoriatic lesions in adalimumab‐treated patients , 2011, Photodermatology, photoimmunology & photomedicine.

[126]  Anil Wipat,et al.  Keratinocyte Apoptosis in Epidermal Remodeling and Clearance of Psoriasis Induced by UV Radiation , 2011, The Journal of investigative dermatology.

[127]  L. Misery,et al.  Ocular damage in patients with psoriasis treated by Psoralen UV‐A therapy or Narrow band UVB therapy: a systematic literature review , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[128]  J. Koo,et al.  Effective treatment of etanercept and phototherapy-resistant psoriasis using the excimer laser. , 2012, Dermatology online journal.

[129]  L. Misery,et al.  Efficacy of Psoralen UV‐A therapy vs. Narrowband UV‐B therapy in chronic plaque psoriasis: a systematic literature review , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[130]  H. Orzechowski,et al.  S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[131]  L. Misery,et al.  Carcinogenic risks of Psoralen UV‐A therapy and Narrowband UV‐B therapy in chronic plaque psoriasis: a systematic literature review , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[132]  L. Belo,et al.  Principal Determinants of the Length of Remission of Psoriasis Vulgaris After Topical, NB-UVB, and PUVA Therapy , 2013, American Journal of Clinical Dermatology.

[133]  W. Weger,et al.  Treatment with 311‐nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab‐treated patients: a randomized intraindividual trial , 2012, The British journal of dermatology.

[134]  L. Sawyer,et al.  Assessment and management of psoriasis: summary of NICE guidance , 2012, BMJ : British Medical Journal.

[135]  H. Orzechowski,et al.  German S3-guidelines on the treatment of psoriasis vulgaris (short version) , 2012, Archives of Dermatological Research.

[136]  M. El-Domyati,et al.  Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis , 2013, Photodermatology, photoimmunology & photomedicine.

[137]  G. Liu,et al.  Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis. , 2013, The Cochrane database of systematic reviews.

[138]  N. J. Eungdamrong,et al.  TREM-1 as a Potential Therapeutic Target in Psoriasis , 2013, The Journal of investigative dermatology.

[139]  N. Reynolds,et al.  Spectral effects of UV on psoriasis† †This article is published as part of a themed issue on current topics in photodermatology. , 2012, Photochemical & Photobiological Sciences.

[140]  B. Ortel,et al.  Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque‐type psoriasis , 2013, The British journal of dermatology.

[141]  S. Yamazaki,et al.  Photo(chemo)therapy Reduces Circulating Th17 Cells and Restores Circulating Regulatory T Cells in Psoriasis , 2013, PloS one.

[142]  J. Koo,et al.  Goeckerman regimen for management of psoriasis refractory to biologic therapy: the University of California San Francisco experience. , 2013, Journal of the American Academy of Dermatology.

[143]  A. Troxel,et al.  Patient satisfaction with treatments for moderate‐to‐severe plaque psoriasis in clinical practice , 2014, The British journal of dermatology.

[144]  Lukman Thalib,et al.  Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta‐analysis , 2015, Photodermatology, photoimmunology & photomedicine.